Pb2198: Effects of Novel Coronavirus Vaccination on the Collection of Peripheral Blood Hematopoietic Stem Cells From Healthy Donors
Year: 2022
Type: conference-abstract
Study design: Observational Study
Abstract: Background: With the development and marketing of the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) vaccine, vaccination has become an effective way to block the novel coronavirus disease 2019 (COVID-19) the most efficient way to spread. Hematopoietic stem cell transplantation (HSCT) is one of the important means for the treatment of aplastic anemia, multiple myeloma, leukemia, lymphoma, myelodysplastic syndrome, autoimmune diseases and other hematological diseases. Peripheral blood hematopoietic stem cell (PBSC) transplantation has the advantages of convenient collection, small impact on donors, good tolerance of donors and recipients, fast and durable recovery of hematopoietic function and immune function of patients after transplantation, and low transplantation-related mortality. However, it is unknown whether the novel coronavirus vaccine has any effect on the collection of peripheral blood hematopoietic stem cells from transplant donors. Aims: To compare the effects of unvaccinated and vaccinated novel coronavirus vaccine on the collection of peripheral blood hematopoietic stem cells from healthy donors. Methods: A retrospective analysis was made on the 112 times of peripheral blood hematopoietic stem cell apheresis conducted by 59 healthy donors who were not vaccinated with the new crown vaccine and 41 healthy donors who were vaccinated with the new crown vaccine in the Affiliated Hospital of Shandong University of traditional Chinese medicine from February 6, 2017 to February 11, 2022, and the quality of hematopoietic stem cell collection products was evaluated by MNC count and CD34+ count. Results: There was no significant difference in gender, age and collection times between the two groups (P>0.05). The MNC count collected in the unvaccinated group was (7.99±2.38) ×108/kg, and the CD34+ count was (3.24±0.69) ×106/kg. The MNC count collected in the vaccinated group was (7.97±3.71)×108/kg, and the CD34+ count was (3.41±0.59) ×106/kg. There was no significant difference between the two groups (P>0.05). - Unvaccinated group Vaccination group P Sex 0.441 Male 39 (66.10%) 24 (58.54%) Female 20 (33.90%) 17 (41.46%) Collection times Once 52(88.14%) 36(87.80%) 0.960 Twice 7(11.86%) 5(12.20%) Age 35.47±14.93 31.54±14.36 0.191 MNC 7.99±2.38 7.97±3.71 0.980 CD34+ 3.24±0.69 3.41±0.59 0.194 Summary/Conclusion: In this preliminary study, we found that the novel coronavirus vaccine had no effect on MNC and CD34+ counts in peripheral blood hematopoietic stem cell collection products from healthy donors. However, these findings require further investigation in larger randomized studies to be validated.
Source: HemaSphere
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,480
OpenAlex ID: W4283380098
